identified a subset of tumor‐specific CD8+ T cells in the TDLNs that retain memory‐like characteristics instead of undergoing functional exhaustion, which exhibit enhanced anti‐tumor efficacy following adoptive transfer and are responsive to ICIs.[139] Similarly, Schenkel et al. This evidence concerns the gene CD8A and neoplasm.